Supplementary file 1_Treatment patterns and impact of glucocorticoids on health outcomes in generalized myasthenia gravis: a retrospective observational study based on the Medical Data Vision database in Japan.docx

Supplementary file 1_Treatment patterns and impact of glucocorticoids on health outcomes in generalized myasthenia gravis: a retrospective observational study based on the Medical Data Vision database in Japan.docx

Introduction<p>Generalized myasthenia gravis (gMG) is a rare, chronic, autoimmune disorder with a substantial disease burden. Oral glucocorticoids (GCs) are one of the common early-line treatments used globally, but there are growing concerns regarding risks associated with GC adverse effects,...

Full description

Saved in:
Bibliographic Details
Main Author: Hirofumi Teranishi (12238595) (author)
Other Authors: Koichi Tsuda (21023276) (author), Daisuke Harada (289517) (author), Challa Yachendra (22409275) (author), Anthony Nguyen (312850) (author), Mai Sato (14592243) (author), Masanori P. Takahashi (12677096) (author), Cécile Blein (4392379) (author)
Published: 2025
Subjects:
Neurology and Neuromuscular Diseases
corticosteroids
intravenous immunoglobulin
myasthenia gravis
real-world evidence
osteoporosis
early fast-acting treatment
steroid-sparing
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items